FDA approves an AbbVie NDA for Emblaveo (aztreonam and avibactam), a combination antibiotic for combination use with metronidazole in patients with co...
A group of 24 Senate Democrats write HHS and urge an end to the ongoing and unprecedented freeze on all external communications and funding at governm...
FDA accepts for priority review an Insmed NDA for brensocatib for treating patients with non-cystic fibrosis bronchiectasis.
FDA issues an alert about Bard Peripheral Vasculars Rotarex Atherectomy Systems due to risks of fracture or breakage.
A Pacific Research Institute white paper makes the case for a preemption defense in failure-to-market cases brought under state laws.
Cooley attorneys say a recent 4th Circuit Court of Appeals decision threatens the practice of medicine defense, giving FDA an additional enforcement m...
FDA grants Onc.AI a breakthrough device designation for its Serial CT Response Score AI model, which the company describes as an artificial intelligen...
FDA says the Medline Industries recall of integrated arterial catheters is Class 1.